C
씨엑스아이
900120KOSDAQ기타 금융업47.5 / 100
Reference Date: 2026-06-10
Financial Score13.0 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 1.5% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
CXI focuses on the production and sales of health foods in China, capitalizing on the rapidly growing Chinese health food market. While the market shows significant growth potential, challenges such as insufficient R&D investment, over-advertising, and counterfeit products remain notable issues.
Number of Employees
—
Average Salary
—
Score Calculation Basis
Detailed Financial Score
PER
222.42Industry Average 9.680.0Point
23.0x industry avg (risky)
PBR
5.62Industry Average 0.460.0Point
12.2x industry avg (risky)
ROE
2.56Industry Average 5.411.0Point
Well below industry avg
Debt Ratio
0.11Industry Average 16.698.0Point
Half of industry avg (excellent)
Trend 2023~20254.0 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼10.6% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲60.8% (2-year basis)
ROE Trend
1.0 / 4
Avg ROE 3.7% (improving, 3yr)
Detailed News Sentiment
1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50
- Neutral씨엑스아이, 최대주주 대상 72억원 규모 유상증자 결정
씨엑스아이의 유상증자 결정으로 자금 조달 계획이 발표되었으나, 직접적인 시장 영향은 제한적임.
Detailed Momentum
52-week position1.0Point
Near 52w low (6%, downtrend)
Current 391Won52-week high 91552-week low 352
1-month return3.0Point
1m -1.51% (flat)
Volume trend6.0Point
Volume surge
Detailed Disclosure
6 totalPositive 1Neutral 5Negative 0
- Neutral감자완료2026-06-04
- Positive주요사항보고서(유상증자결정)2026-06-04
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-06-02
- Neutral분기보고서 (2026.03)2026-06-01
- Neutral[기재정정]주식매수선택권부여에관한신고2026-05-21